linkedin
 
You Are On
Equity
Equity Analysis
News Analysis
Corporate Action
Corporate Info
Derivatives
Other Market
Research
 
 Board Meetings  
Zydus Lifesciences Ltd.
 
Source DateBoard Meeting DateDetails
27 Jan 202609 Feb 2026 Quarterly Results
29 Oct 202506 Nov 2025 Quarterly Results & Inter alia, shall also consider the proposal for raising funds up to Rs. 5,000 Crores (Rupees Five Thousand Crores only) through the issuance of eligible securities of the Company by way of qualified institutions placement(s), rights issue, preferential allotment or a private placement(s) and/or any combination thereof or any other method as may be permitted under applicable laws, subject to the approval of the members of the Company and such regulatory / statutory approvals as may be required. The Board would also consider convening a postal ballot process to seek approval of the shareholders of the Company in respect of the aforesaid proposal, as required.
01 Aug 202512 Aug 2025 Quarterly Results
09 May 202520 May 2025 Final Dividend & Audited Results
21 Jan 202505 Feb 2025 Quarterly Results
30 Oct 202412 Nov 2024 Quarterly Results
18 Jul 202409 Aug 2024 Quarterly Results
09 May 202417 May 2024 Final Dividend & Audited Results
29 Jan 202409 Feb 2024 Quarterly Results & Buy Back of Shares
30 Oct 202307 Nov 2023 Quarterly Results
31 Jul 202311 Aug 2023 Quarterly Results
12 May 202318 May 2023 Final Dividend & Audited Results
23 Jan 202303 Feb 2023 Quarterly Results
31 Oct 202211 Nov 2022 Quarterly Results
03 Aug 202210 Aug 2022 Quarterly Results
13 May 202220 May 2022 Final Dividend & Audited Results
25 Jan 202203 Feb 2022 Quarterly Results
20 Oct 202129 Oct 2021 Quarterly Results
03 Aug 202111 Aug 2021 Quarterly Results
21 May 202127 May 2021 Final Dividend & Audited Results
Page 1 of 6
Prev || Next
 
RMS | Policies & Procedures| PMLA | Disclaimer | Privacy Policy | Web Mail | Relationship | Investor Grievance
Career | Contact Us| KYC| PMS Risk Disclosure | Key Managerial Person | Basic Details | Process of Opening an Account | Process of Filing Complaint
Links to MCX | NCDEX |FMC | NCDEX CMID NCDEX-CO-04-00129 | MCX 10550 | FMC MCX: MCX/TCM/CORP/0008| FMC NCDEX : NCDEX/TCM/CORP/0274    
NSE: INB230914036 |NSE F & O INF230914036 |BSE: INB010914032 |BSE F & O: INF010914032 | CDSL: IN-DP-CDSL-335-2006 | OTC: INB200914032
Related Sites: Bombay Stock Exchange (BSE), Investor Protection, National Stock Exchange (NSE), Securities & Exchange Board of India (SEBI)
© Padmakshi 2009. All Rights Reserved. Designed || Developed & Content Powered By Accord Fintech Pvt. Ltd.